Nesiritide is the recombinant form of the 32 amino acid human B-type natriuretic peptide (BNP), which is normally produced by the ventricular myocardium. Human BNP binds to the particulate guanylate cyclase receptor of vascular smooth muscle and endothelial cells, leading to increased intracellular concentrations of guanosine 3'5'-cyclic monophosphate (cGMP) and smooth muscle cell relaxation. Cyclic GMP serves as a second messenger to dilate veins and arteries. Nesiritid was sold under brand name Natrecor for the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2111337 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | NATRECOR Approved UseNATRECOR® is a natriuretic peptide indicated for the treatment of patients with acutely decompensated heart failure who have dyspnea at rest or with minimal activity. In this population, the use of NATRECOR® reduced pulmonary capillary wedge pressure and improved symptomatic dyspnea when measured at 3 hours of infusion Launch Date2001 |
Sample Use Guides
The recommended dose of Natrecor (nesiritide) is an IV bolus of 2 µg/kg followed by a continuous infusion at a dose of 0.01 µg/kg/min. Natrecor should not be initiated at a dose that is above the recommended dose. Prime the IV tubing with an infusion of 25 mL prior to connecting to the patient's vascular access port and prior to administering the bolus or starting the infusion.
Route of Administration:
Intravenous
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 00:28:22 GMT 2023
by
admin
on
Sat Dec 16 00:28:22 GMT 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
EL5U85UKD2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C95607
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
56841835
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
189032-40-4
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
CHEMBL2109183
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
JJ-58
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
SUB22388
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
DTXSID00172291
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY | |||
|
EL5U85UKD2
Created by
admin on Sat Dec 16 00:28:23 GMT 2023 , Edited by admin on Sat Dec 16 00:28:23 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_10 | 1_26 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
STARTING MATERIAL -> INGREDIENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:FORMULA | CHEMICAL |
|